common.study.topics.clinical

Testing Experimental Medication in Healthy Subjects

common.study.values.description

“A Single Ascending Dose Trial of CVL-936 in Healthy Subjects”

The aim of this trial is to investigate the safety, tolerability, pharmacokinetics (PK), and pharmacodynamics (PD) of CVL-936 following single ascending oral doses in healthy subjects.

common.study.values.location

participant.ui.study.affiliations-map.online-study.header-virtual

participant.ui.study.affiliations-map.online-study.text

participant.ui.study.affiliations-map.legend.locations participant.ui.study.affiliations-map.legend.selected

common.study.values.methods

Pharmaceutical medication involved common.study.methods.has-drugs-yes
Patients and healthy individuals accepted common.study.methods.is-healthy-no

Drug - CVL-936

CVL-936

Drug - Matching Placebo

Placebo matching CVL-936

participant.views.study.view.additional

participant.views.study.view.scientific-title

A Phase 1, Double-Blind, Sponsor-Open, Placebo-Controlled, First-In-Human Trial To Evaluate The Safety, Tolerability, Pharmacokinetics, And Pharmacodynamics Of Single Ascending Doses of CVL-936 In Healthy Subjects

common.study.values.clinical-trial-id

NCT04232878

participant.views.study.view.id

dR6p0d